Gonzalez Named Top Lobbyist by The National Institute for Lobbying and Ethics

The National Institute for Lobbying and Ethics named Ariel Gonzalez as one of the Top Lobbyists for 2021.  This merit-based distinction spotlights professionals that showed significant success in 2021, took an innovative approach to their field, and demonstrated commitment to give back to their community and profession, as well as adherence to the highest ethical standards. The list is comprised of lobbyists, PAC managers, and grassroots professionals that have been nominated by their colleagues, Congressional staff, or clients for their outstanding work.

Gonzalez Named to the Board of Directors for the Maternal Mental Health Leadership Alliance

The Maternal Mental Health Leadership Alliance (MMHLA) has named Ariel Gonzalez, principal, to their Board of Directors.  MMHLA is a nonpartisan nonprofit organization dedicated to promoting the mental health of childbearing people in the United States by advocating for mental health during pregnancy and the year following pregnancy with a focus on federal legislation, and by sharing information about these conditions with others in the fields of maternal-child healthcare and mental health.  In his role, Ariel will provide leadership to MMHLA as they raise awareness about maternal mental health (MHH) conditions, reducing their stigma and improving health outcomes for mothers and babies. He will draw upon his experience in the mental health and maternal health arenas from his past leadership with the American Psychiatric Association and the March of Dimes.

Bell: What to Expect in 2021

Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!

Bell Discusses Healthcare Equity

In the final episode of A&M Healthcare Industry Group’s podcast series on the impact of the new Administration, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, and Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, discussed the Biden Administration’s commitment to “equity” in healthcare. The experts also weigh in to provide some perspectives on who is on the “in” and who is on the “out” in this Administration.

Bell Talks Rx Pricing Reform

In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continued their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition.  They also discussed the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.

Source

Bell Previews Impact of the New Administration on Healthcare Policy

A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discussed and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.

In part one, Dr. Shulkin and Ms. Bell discussed the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discussed the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.